Animal study · mice
BPC-157 reduced radiation liver injury in mice and rat liver cells
Checked against the paper Animal studyPublished by PepVault
The takeaway
This adds early animal and cell evidence that BPC-157 by mouth reduced radiation liver damage in mice, but it has not been tested for this in people.
- Kind
- Animal study
- Studied in
- Mice
- Published
- 2022
- Journal
- Life Sci
What they tested
The team tested whether BPC-157 protects the liver from damage caused by radiation.
How the study was done
An animal and cell study. Mice received a single 12 Gy dose of radiation to cause acute liver injury, with or without BPC-157 by mouth, and rat liver cells (clone 9) were studied in the lab, including cells where the protein KLF4 was switched off.

What they found
In mice, BPC-157 lowered blood levels of AST and ALT, two liver enzymes, after radiation and reduced hydropic degeneration, a kind of swelling damage, in the liver. In both mouse liver and rat liver cells, it reduced radiation-related apoptosis (programmed cell death) and fat buildup, raised PCNA, a marker of cell growth, raised the protein KLF4, and lowered the protein HIF-2α. When KLF4 was switched off in the rat liver cells, BPC-157 no longer protected them from cell death or fat buildup, which the team took to mean its effect runs through KLF4.
What it doesn’t show
Every result comes from irradiated mice and a rat liver cell line, and none of it was tested in cancer patients getting radiation therapy. The work covered short-term damage after one 12 Gy exposure, not the repeated doses or lasting liver disease seen in treatment.
The paper
Huang et al. Pentadecapeptide BPC 157 efficiently reduces radiation-induced liver injury and lipid accumulation through Kruppel-like factor 4 upregulation both in vivo and in vitro. Life Sci. 2022.
The compound
More studies on BPC-157
- BPC-157: 10 of 12 women reported full interstitial cystitis reliefClinical trial · people · 2024
- BPC-157: 14 of 16 reported knee pain relief in a chart reviewObservational study · people · 2021
- BPC-157: non-significant tendon gains in rats; TB-500 did betterAnimal study · rats · 2026
- BPC-157 reduced leg muscle damage after ischemia-reperfusion in ratsAnimal study · rats · 2026
- BPC-157 closed duodenocolic fistulas in ratsAnimal study · rats · 2024
- BPC-157 limited isoprenaline-induced heart attack damage in ratsAnimal study · rats · 2022
- Every study on BPC-157
Researched and drafted with AI, then checked claim by claim against the primary sources linked below by a separate review pass. Published by PepVault. Last reviewed . Spot an error? feedback@pepvault.app. How we research. This page reports one study; it is not medical advice.